Clinical review of 202 patients with vulval lichen sclerosus: A possible association with psoriasis

Australasian Journal of Dermatology

Volumn 48, Issue 1, 2007, Pages 28-31

  Simpkin, Susan ^a   Oakley, Amanda ^a,b,c  

^a Health Waikato   (New Zealand)

^b Tristram Clinic   (New Zealand)

^c WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Clobetasol propionate; Thyroid disease

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; HYDROXYCHLOROQUINE; PIMECROLIMUS; PREDNISONE; THYROID ANTIBODY; THYROXINE;

ARTICLE; BIOPSY; CONSULTATION; DIAGNOSIS RELATED GROUP; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DYSPAREUNIA; FAMILY HISTORY; FOLLOW UP; GYNECOLOGIC DISEASE; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; LONG TERM CARE; MEDICAL RECORD REVIEW; PERIANAL GLAND; PERINEUM; PSORIASIS; RETROSPECTIVE STUDY; SYMPTOM; THYROID DISEASE; VULVA; VULVA PRURITUS; VULVODYNIA;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CLOBETASOL; FEMALE; HUMANS; INFANT; INTERVIEWS; LICHEN SCLEROSUS ET ATROPHICUS; MEDICAL RECORDS; MIDDLE AGED; NEW ZEALAND; PSORIASIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VULVAR DISEASES;

EID: 33846002729     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2007.00322.x     Document Type: Article

References (23)

1. Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity - a study of 350 women. Br. J. Dermatol. 1988; 118: 41-6.
2. Garcia-Bravo B, Sanchez-Pedreno P, Rodriguez-Pichardo A, Camacho F. Lichen sclerosus et atrophicus. A study of 76 cases and their relation to diabetes. J. Am. Acad. Dermatol. 1988; 19: 482-5.
3. Hacker S. Absence of anti-single-stranded DNA antibodies in vulvar lichen sclerosus et atrophicus. Arch. Dermatol. 1994; 130: 1454-5.
4. Neill SM, Tatnall FM, Cox NH, British Association of Dermatologists. Guidelines for the management of lichen sclerosus. Br. J. Dermatol. 2002; 147: 640-9.
5. Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch. Dermatol. 2004; 140: 702-7.
6. Koo JY. Current consensus and update on psoriasis therapy: a perspective from the U.S. J. Dermatol. 1999; 26: 723-33.
7. Albert S, Neill S, Derrick EK, Calonje E. Psoriasis associated with vulval scarring. Clin. Exp. Dermatol. 2004; 29: 354.
8. Kormeili T, Lowe NJ, Yamauchi PS. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences. Br. J. Dermatol. 2004; 151: 3-15.
9. Pock L. Koebner phenomenon in lichen sclerosus et atrophicus. Dermatologica 1990; 181: 76-7.
10. Harth W, Linse R. Dermatological symptoms and sexual abuse: a review and case reports. J. Eur. Acad. Dermatol. Venereol. 2000; 14: 489-94.
11. Yates VM, King CM, Dave VK. Lichen sclerosus et atrophicus following radiation therapy. Arch. Dermatol. 1985; 121: 1044-7.
12. Milligan A, Graham-Brown RA, Burns DA. Lichen sclerosus et atrophicus following sunburn. Clin. Exp. Dermatol. 1988; 13: 36-7.
13. Sawamura D, Yaguchi T, Hashimoto I, Nomura K, Konta R, Umeki K. Coexistence of generalized morphea with histological changes in lichen sclerosus et atrophicus and lichen planus. J. Dermatol. 1998; 25: 409-11.
14. Goolamali SK, Barnes EW, Irvine WJ, Shuster S. Organ specific antibodies in patients with lichen sclerosus. BMJ 1974; 4: 78-9.
15. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J. Am. Acad. Dermatol. 2001; 44: 803-6.
16. Goldstein AT. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases. J. Reprod. Med. 2004; 49: 778-80.
17. Boms S, Gambichler T, Freitag M, Altmeyer P, Kreuter A. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood. BMC Dermatol. 2004; 4: 14.
18. Gupta S, Saraswat A, Kumar B. Treatment of genital lichen sclerosus with topical calcipotriol. Int. J. STD AIDS 2005; 16: 772-4.
19. Wakelin SH, James MP. Extensive lichen sclerosus et atrophicus with bullae and ulceration - improvement with hydroxychloroquine. Clin. Exp. Dermatol. 1994; 19: 332-4.
20. Scurry J. Does lichen sclerosus play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma? The itch-scratch-lichen sclerosus hypothesis. Int. J. Gynecol. Cancer 1999; 9: 89-97.
21. von Krogh G, Dahlman-Ghozlan K, Syrjanen S. Potential human papillomavirus reactivation following topical corticosteroid therapy of genital lichen sclerosus and erosive lichen planus. J. Eur. Acad. Dermatol. Venereol. 2002; 16: 130-3.
22. Ormerod AD. Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? Br. J. Dermatol. 2005; 153: 701-5.
23. Walkden V, Chia Y, Wojnarowska F. The association of squamous cell carcinoma of the vulva and lichen sclerosus: implications for management and follow up. J. Obstet. Gynaecol. 1997; 17: 551-3.